BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Pseudomonas infection
,
Embryo
,
Metabolism of nitric oxide
,
PTEN
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
dermatologic agents
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Broad Connectivity Map (CMAP 2.0) compound database
Drug target sets for approved compounds
Liver Pharmacology and Xenobiotic Response Repertoire
Explore Curated Studies Results
Literature
Most Relevant Literature
Topical dermatological drug delivery: quo vadis?
Challenges encountered in dermatologic drug development.
Caution advised in interpretation of US FDA risk classification for dermatological medications durin…
Dermatologic medication adherence.
Dermatologic medication in pregnancy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Application of Telemedicine for Dermatological Emergency Patients
Clinical, Psychological and Genetic Characteristics in Dermatological Patients
LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Derma…
AvenovaTM as a Sterile Skin Preparation Agent
Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ